Navigation Links
Pharm-Olam Finds VoIP Solution in Taridium LLC

NEW YORK, May 7 /PRNewswire/ -- When leading contract research organization Pharm-Olam International (POI, upgraded its legacy PBX system to a voice-over Internet protocol (VoIP) system that would better serve the company's global communications needs, the results were nothing short of catastrophic.

POI initially selected a local vendor to plan, develop and deploy a VoIP system, but it was immediately clear the solution was a bigger problem than the old PBX.

"It was a total disaster. The system crashed virtually every day, voice quality was terrible, remote staff had connectivity issues, and the vendor had spend over six months trying to bring the system live in the UK office," stated R. Michael Shassere, POI global director of IT. "I knew I had to find a fix quickly. I also did not want to lose the recent investment in the Polycom desk sets we had just purchased."

So Shassere set about finding a company that could both implement a better VoIP system and correct the problems the local vendor had created. POI executives agreed VoIP -- done right -- was the perfect solution to their needs. The technology was proven, so the obvious issue was the original vendor. Shassere researched larger vendors like Fonality and Switchbox, along with some other local providers.

"I was not impressed, especially with the deployment plans that required significant time from POI IT staff, or with the after-sale support options," Shassere explained. "I had almost lost hope of finding the right vendor when I contacted Taridium. After just a few minutes on the phone, I knew this was the vendor I needed."

POI initially contracted with premier VoIP solutions provider Taridium LLC ( to resolve the system issues in the company's UK office. Taridium brought the system up and operational in just a few short days -- something the previous vendor had failed to do in several months.

"We were elated. Taridium has now installed its system in several of our worldwide sites so far, and we will have them do all the sites as time permits," said Shassere. "We could not be happier."

About Pharm-Olam International

Based in Houston, Texas, POI is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. The company has experienced significant growth in the past few years and now has offices located in 22 countries around the globe. More information is available at

About Taridium LLC

Taridium is the leader in open standards enterprise and provider VoIP solutions. The company's offering ranges from managed VoIP services for small and medium-sized businesses to high-capacity telephony solutions for large enterprises and service providers. Taridium's products and services are designed to harness the power of open standards while reducing both ownership and telecommunication expenses. To learn more, visit


R. Michael Shassere

Pharm-Olam International


Astra Baxley

Taridium LLC


This release was issued through eReleases(TM). For more information, visit

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Phase III Trial Finds Pharmaxis Bronchitol Effective
2. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
3. HU scientist finds way to catch terrorists red-handed
4. Study Finds Widespread Vitamin and Mineral Use Among Cancer Survivors, Although Benefits of Such Use Remain Unclear
5. Unique infrared technique finds applications in nanoscience
6. Study Finds Broadband Access Key to Empowerment of Minority Communities
7. Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood
8. Skin & Aging Article Finds Derma Sciences MEDIHONEY(TM) Helps to Promote Healing Where Antibiotics Fail
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
11. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
Post Your Comments:
(Date:11/25/2015)... 26, 2015 --> ... 2016 - 2020 report analyzes that automating biobanking ... quality in long-term samples, minimizing manual errors, improving ... minimizes manual errors such as mislabeling or inaccurate ... it plays a vital role in blood fractionation, ...
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... uBiome, were featured on AngelList early in their initial angel funding process. Now, ... syndicate for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or "the ... results for the quarter ended September 30, 2015. ... dollars and presented under International Financial Reporting Standards ... ," said Andrew Rae , President & ... are not only value enriching for this clinical ...
Breaking Biology Technology:
(Date:11/20/2015)... 20, 2015 NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... , was recently interviewed on The RedChip Money ... this weekend on Bloomberg Europe , Bloomberg Asia, ... --> NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:11/19/2015)... Nov. 19, 2015  Although some 350 companies are ... by a few companies, according to Kalorama Information. These include ... of the market share of the 6.1 billion-dollar molecular ... World Market for Molecular Diagnostic s .    ... is still controlled by one company and only a ...
(Date:11/18/2015)... New York , November 18, 2015 ... Market Research has published a new market report titled ... Growth, Trends, and Forecast, 2015 - 2021. According to the ... in 2014 and is anticipated to reach US$29.1 bn ... to 2021. North America ...
Breaking Biology News(10 mins):